RE:RE:RE:RE:RE:RE:RE:New corporate presentation 2790bafc-6443-4aed-a90c-1cb2957c3330
2790bafc-6443-4aed-a90c-1cb2957c3330
https://www.theratech.com/static-files/8d86c08a-229e-4e9c-8ad2-ef353b8a4fbf
“Part 1 of the study is currently open to recruitment only in the USA. Once MTD, RD and safety are established, part 2 (expansion) will open in sites in the USA, UK, and Europe.”
https://www.theratech.com/medicines-pipeline/pipeline-and-science/oncology/clinical-trials
I can’t see anything new apart from SP and market cap.
I don’t look often at the website but there is a patient information page for Oncology , Hepatology which might not be new?
https://www.theratech.com/medicines-pipeline/pipeline-and-science/oncology/patient-need
https://www.theratech.com/medicines-pipeline/pipeline-and-science/hepatology/patient-need
Even mentioning opening sites in the USA, UK and Europe might not be new but they are there so it will be interesting when and how many more sites if any will start enrolling. The intraday volume increased significantly today and now there are more than there are more than 1000 followers on Stocktwits which must be record as long as I remember. Both are positive developments in my opinion so a bit more exposure, more liquidity, less volatility etc. Hopefully this is the start of an ongoing trend going forward.
I have said it many and too few times don’t underestimate the power of the retail investors!